Posts for Ticker ‘IDIX’

Long Line of Biotech Secondary Stock Offerings (MNKD, IDIX, ISPH, ARIA, ONTY, NBY, SOMX, ARNA, OXGN)

Money Stack ImageIt seems that there is another endless line of biotech and emerging pharmaceutical companies which have raised cash or have filed to raise cash.  MannKind Corporation (NASDAQ: MNKD), Idenix Pharmaceuticals Inc. (NASDAQ: IDIX), and Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) have all priced secondary offerings of common stock for close to $175 million total among all three offerings this morning alone.  Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) had its pricing yesterday of a secondary offering and Oncothyreon Inc. (Nasdaq: ONTY) announced terms for a direct offering of securities.   NovaBay Pharmaceuticals, Inc. (NYSE: NBY) filed this week for a capital raise.

Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX), Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), and OXiGENE, Inc. (NASDAQ: OXGN) have all filed this week with the SEC for the resale of securities by secondary offering and private placement buyers in recent weeks.

You can read the full story with details on each offering over at BioHealthInvestor.com.

And imagine this… it is only Wednesday.

-The 24/7 Wall St. Team

Posted on: August 5, 2009 – 1:28 pm in Biotech, Secondary Offering, , , , , , , , ,

Top Day Trader Alerts (ALKS, LLY, SNY, MRK, SPPI, LXK, BSX, JDAS, IDIX, PKG, CVBF, WERN)

These are some of this morning’s top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and volume analysis at VSInvestor.com:

Alkermes Inc. (Nasdaq: ALKS) shares are ones to watch for volume upside following positive study results that may also affect shares of Eli Lilly & Co. (NYSE: LLY) and Sanofi Aventis (NYSE: SNY).

Merck & Co. (NYSE: MRK) shares are up over 3% after it beat EPS by 6 cents a share and reaffirmed fiscal 2009 guidance.

Spectrum Pharmaceuticals Inc. (Nasdaq: SPPI) shares are rising in premarket trade after getting FDA fast-track status for a bladder cancer candidate.

Lexmark International Group Inc. (NYSE: LXK) shares are ones to watch for volume downside after it missed expectations by 5 cents a share and guided Q3 EPS lower.

JDA Software Group Inc. (Nasdaq: JDAS) are ones to watch for volume upside after it posted  a 17-cent a share EPS beat.

Idenix Pharmaceuticals Inc. (Nasdaq: IDIX) shares are ones to watch for volume downside after it missed EPS expectations by 3 cents a share.

Packaging Corp. of America (NYSE: PKG) shares are ones to watch for volume upside following a 12-cent EPS beat.

Boston Scientific (NYSE: BSX) is up strongly in early premarket trade on stronger-than-expected earnings.

CVB Financial Corp. (Nasdaq: CVBF) shares are ones to watch for downside after it announced a stock offering.

Werner Enterprises Inc. (Nasdaq: WERN) are ones to watch for volume downside on concerns about a revenue miss.

-The 24/7 Wall St. Team

Posted on: July 21, 2009 – 7:40 am in Pre-Market Activity, Trading Alert, , , , , , , , , , , ,

52-Week Lows (July 13, 2007) (ACA, AVAV, IDIX, KERX, NKTR, REDE, STAA, TRMP, UBET, WON)

Stock Tickers: ACA, AVAV, IDIX, KERX, NKTR, REDE, STAA, TRMP, UBET, WON

The DJIA & S&P 500 Index may have put in new highs today, but as you know there are always a dingy group of little piggies putting in new 52-week lows.  Some companies are poorly run, and some are just victim of circumstance.  Maybe they can just all blame Friday the 13th.  Not all of these are definitely CLOSING on 52-week lows but some deserved the honorable mention.  Here are today’s little piggies:

(ACA) ACA CAPITAL HOLDINGS… Giving it up again, down 50% from Highs.  ACA provides financial guaranty insurance products to participants in the global credit derivative, structured finance capital, and municipal finance capital markets.  You think subprime or CDO blow-ups snuck into their pocketbook?

(AVAV) AEROVIRONMENT INC… Shares traded down another 2.4% and traded down into the ‘teens’ for the first time since its IPO in January.  No one realized that its flying re-con plane was needed to find stock buyers rather than enemy soldiers over the horizon.

(IDIX) IDENIX PHARMACEUTICALS… Whoops, FDA halts Hep-C trials. Ouch!

(KERX)    KERYX BIOPHARMA… no real news, just days and days of weakness.

(NKTR) NEKTAR THERAPEUTICS… no real news, just days of weakness.

(REDE) RED ENVELOPE… no real news, although for an ‘online of high-end gifts’ it is pretty shocking that I have yet to meet anyone who has bought from them online.

(STAA) STAAR SURGICAL… very thin volume, no news; not being run by stars?

(TRMP) TRUMP ENTERTAINMENT… The truth is that this DIDN’T CLOSE on a low, but it hit a new since coming public after the recapitalization in 2005 and deserves to be noted.  Hopefully The Donald won’t sue us for saying something negative like he has been known to do, but this stock has been a stinker.

(UBET) YOUBET.COM… You can bet it is hard to find bulls or bears in this name.

(WON) WESTWOOD ONE INC… This was down close to 15% at one point but managed to come all the way back on 4-times average volume to a 10-year ("TEN") after traders bought it back up after Citigroup downgraded it.

Jon C. Ogg
July 13, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: July 13, 2007 – 3:03 pm in HI/LOW, , , , , , , , , ,

Biotech Implosion: Idenix Pharmaceuticals (IDIX)

Idenix Pharma (NASDAQ:IDIX) this morning announced that its Valopicitabine development program was placed on clinical hold in the United States after discussions with the FDA.  Unfortunately this was the company’s hoped-for hepatitis C treatment.

Jean- Pierre Sommadossi, Ph.D., chairman & CEO of Idenix: "We are disappointed with the FDA’s perspective on the program and are working with Novartis to evaluate our options for valopicitabine.  We remain committed to building a leading antiviral franchise and will continue to focus on ensuring a successful launch of Tyzeka®/Sebivo® and on advancing our pipeline. We have a novel non-nucleoside reverse transcriptase inhibitor being evaluated in phase I clinical testing for the treatment of HIV. Additionally, we have a comprehensive HCV discovery effort, which includes a second-generation nucleoside polymerase inhibitor that is being evaluated in IND-enabling preclinical testing and novel HCV non-nucleoside polymerase inhibitor and HCV protease inhibitor programs."

The company claims approximately $160 million of cash on hand at June 30 and said it will be reviewing expenses and will review investing in programs it thinks can maximize shareholder value.  As of March 31 it carried $82.646 million in total liabilities, so don’t look at that cash level as "net cash after liabilities."

Shares are down 17% to $4.78 pre-market, down 17% or so from the $5.59 52-week low and down well over 50% from the $11.21 52-week highs.  Its market cap before this drop was $325 million.

Jon C. Ogg
July 13, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: July 13, 2007 – 7:38 am in Uncategorized,

Pre-Market Stock News (July 13, 2007)

(AA) Alcoa may now be in play according to research notes since it withdrew Alcan bid.
(APA) Apache may go to $100.00 and then trade up to $120.00 according to Cramer.
(BHI) Baker Hughes put Q2 2007 EPS at $1.07 to $1.09, down from $1.17 last quarter due to deterioration of activity and profitability in Canada.
(CHINA) CDC Corp intends to offer up to $200 million of CDC Games in an IPO.
(DYAX) Dyax priced a 10.5M share stock offering atr $3.67 per share.
(EVST) Everlast BOD was sent a letter by Aquamarine Capital Management urging it to maximize shareholder value.
(GE) General Electric $0.52 EPS vs $0.52e; revenues ahead of estimates and increased shares under buyback; selling sub-prime unit.
(GWR) Genessee & Wyoming said rail carloads fell 7% to 67,165 carloads.
(IDIX) Idenix Pharma says Valopicitabine development program placed on clinical hold in the United States.
(PYX) Playtex Products being acquired by Energizer Holdings.
(XING) Qiao Xing will file annual report on July 16.

Jon C. Ogg
July 13, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: July 13, 2007 – 7:22 am in Pre-Market Activity, , , , , , , , , , , ,